BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 36050751)

  • 1. Diagnostic value of integrated
    Yu Y; Zhang L; Sultana B; Wang B; Sun H
    BMC Cancer; 2022 Sep; 22(1):947. PubMed ID: 36050751
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preoperative pelvic MRI and 2-[
    Fasmer KE; Gulati A; Dybvik JA; Wagner-Larsen KS; Lura N; Salvesen Ø; Forsse D; Trovik J; Pijnenborg JMA; Krakstad C; Haldorsen IS
    Eur Radiol; 2023 Jan; 33(1):221-232. PubMed ID: 35763096
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolic Tumor Volume on 18F-FDG PET/CT Improves Preoperative Identification of High-Risk Endometrial Carcinoma Patients.
    Husby JA; Reitan BC; Biermann M; Trovik J; Bjørge L; Magnussen IJ; Salvesen ØO; Salvesen HB; Haldorsen IS
    J Nucl Med; 2015 Aug; 56(8):1191-8. PubMed ID: 26045311
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic value of
    Tsuyoshi H; Tsujikawa T; Yamada S; Okazawa H; Yoshida Y
    Cancer Imaging; 2020 Oct; 20(1):75. PubMed ID: 33092631
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FDG PET/CT diagnostic criteria may need adjustment based on MRI to estimate the presurgical risk of extrapelvic infiltration in patients with uterine endometrial cancer.
    Sudo S; Hattori N; Manabe O; Kato F; Mimura R; Magota K; Sugimori H; Hirata K; Sakuragi N; Tamaki N
    Eur J Nucl Med Mol Imaging; 2015 Apr; 42(5):676-84. PubMed ID: 25504022
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Value of fusion of PET and MRI for staging of endometrial cancer: comparison with ¹⁸F-FDG contrast-enhanced PET/CT and dynamic contrast-enhanced pelvic MRI.
    Kitajima K; Suenaga Y; Ueno Y; Kanda T; Maeda T; Takahashi S; Ebina Y; Miyahara Y; Yamada H; Sugimura K
    Eur J Radiol; 2013 Oct; 82(10):1672-6. PubMed ID: 23727380
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preoperative 18F-FDG PET/CT tumor markers outperform MRI-based markers for the prediction of lymph node metastases in primary endometrial cancer.
    Fasmer KE; Gulati A; Dybvik JA; Ytre-Hauge S; Salvesen Ø; Trovik J; Krakstad C; Haldorsen IS
    Eur Radiol; 2020 May; 30(5):2443-2453. PubMed ID: 32034487
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of FDG PET/CT and MRI in lymph node staging of endometrial cancer.
    Kim HJ; Cho A; Yun M; Kim YT; Kang WJ
    Ann Nucl Med; 2016 Feb; 30(2):104-13. PubMed ID: 26546334
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic Accuracy of FEC-PET/CT, FDG-PET/CT, and Diffusion-Weighted MRI in Detection of Nodal Metastases in Surgically Treated Endometrial and Cervical Carcinoma.
    Rockall AG; Barwick TD; Wilson W; Singh N; Bharwani N; Sohaib A; Nobbenhuis M; Warbey V; Miquel M; Koh DM; De Paepe KN; Martin-Hirsch P; Ghaem-Maghami S; Fotopoulou C; Stringfellow H; Sundar S; Manchanda R; Sahdev A; Hackshaw A; Cook GJ;
    Clin Cancer Res; 2021 Dec; 27(23):6457-6466. PubMed ID: 34526364
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 18F-FDG PET/CT findings in endometrial cancer patients: the correlation between SUVmax and clinicopathologic features.
    Boonya-ussadorn T; Choi WH; Hyun J; Kim SH; Chung SK; Yoo IeR
    J Med Assoc Thai; 2014 Feb; 97 Suppl 2():S115-22. PubMed ID: 25518184
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hybrid PET/MRI in Staging Endometrial Cancer: Diagnostic and Predictive Value in a Prospective Cohort.
    Ironi G; Mapelli P; Bergamini A; Fallanca F; Candotti G; Gnasso C; Taccagni GL; Sant'Angelo M; Scifo P; Bezzi C; Bettinardi V; Rancoita PMV; Mangili G; Bocciolone L; Candiani M; Gianolli L; De Cobelli F; Picchio M
    Clin Nucl Med; 2022 Mar; 47(3):e221-e229. PubMed ID: 35067539
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional images reflect aggressiveness of endometrial carcinoma: estrogen receptor expression combined with 18F-FDG PET.
    Tsujikawa T; Yoshida Y; Kudo T; Kiyono Y; Kurokawa T; Kobayashi M; Tsuchida T; Fujibayashi Y; Kotsuji F; Okazawa H
    J Nucl Med; 2009 Oct; 50(10):1598-604. PubMed ID: 19759112
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined pre-treatment MRI and 18F-FDG PET/CT parameters as prognostic biomarkers in patients with cervical cancer.
    Miccò M; Vargas HA; Burger IA; Kollmeier MA; Goldman DA; Park KJ; Abu-Rustum NR; Hricak H; Sala E
    Eur J Radiol; 2014 Jul; 83(7):1169-1176. PubMed ID: 24767630
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of the integrated FDG PET/CT in the surgical management of patients with high risk clinical early stage endometrial cancer: detection of pelvic nodal metastases.
    Signorelli M; Guerra L; Buda A; Picchio M; Mangili G; Dell'Anna T; Sironi S; Messa C
    Gynecol Oncol; 2009 Nov; 115(2):231-5. PubMed ID: 19695685
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tailoring systematic lymphadenectomy in high-risk clinical early stage endometrial cancer: the role of 18F-FDG PET/CT.
    Crivellaro C; Signorelli M; Guerra L; De Ponti E; Pirovano C; Fruscio R; Elisei F; Montanelli L; Buda A; Messa C
    Gynecol Oncol; 2013 Aug; 130(2):306-11. PubMed ID: 23707673
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic role of FDG PET-derived parameters in preoperative staging of endometrial cancer.
    Mapelli P; Bergamini A; Fallanca F; Rancoita PMV; Cioffi R; Incerti E; Rabaiotti E; Petrone M; Mangili G; Candiani M; Gianolli L; Picchio M
    Rev Esp Med Nucl Imagen Mol (Engl Ed); 2019; 38(1):3-9. PubMed ID: 30573387
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic value of lymph node-to-primary tumor standardized uptake value ratio in endometrioid endometrial carcinoma.
    Chung HH; Cheon GJ; Kim JW; Park NH; Song YS
    Eur J Nucl Med Mol Imaging; 2018 Jan; 45(1):47-55. PubMed ID: 28828510
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic value of preoperative metabolic tumor volume measured by ¹⁸F-FDG PET/CT and MRI in patients with endometrial cancer.
    Chung HH; Lee I; Kim HS; Kim JW; Park NH; Song YS; Cheon GJ
    Gynecol Oncol; 2013 Sep; 130(3):446-51. PubMed ID: 23791826
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preoperative risk stratification using metabolic parameters of (18)F-FDG PET/CT in patients with endometrial cancer.
    Kitajima K; Suenaga Y; Ueno Y; Maeda T; Ebina Y; Yamada H; Okunaga T; Kubo K; Sofue K; Kanda T; Tamaki Y; Sugimura K
    Eur J Nucl Med Mol Imaging; 2015 Jul; 42(8):1268-75. PubMed ID: 25833351
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combining positron emission tomography/computed tomography, radiomics, and sentinel lymph node mapping for nodal staging of endometrial cancer patients.
    Crivellaro C; Landoni C; Elisei F; Buda A; Bonacina M; Grassi T; Monaco L; Giuliani D; Gotuzzo I; Magni S; Di Martino G; Delle Marchette M; Guerra L; Landoni F; Fruscio R; Messa C; De Bernardi E
    Int J Gynecol Cancer; 2020 Mar; 30(3):378-382. PubMed ID: 32079712
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.